Mechanisms for the development of bone metastases and hypercalcaemia in patients with breast cancer
- PMID: 323867
- PMCID: PMC1543002
- DOI: 10.1177/003591577707000319
Mechanisms for the development of bone metastases and hypercalcaemia in patients with breast cancer
Similar articles
-
Calcium metabolism in breast cancer.Proc R Soc Med. 1977 Mar;70(3):195-9. doi: 10.1177/003591577707000318. Proc R Soc Med. 1977. PMID: 870901 Free PMC article.
-
E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model.Cancer Res. 1996 Sep 1;56(17):4063-70. Cancer Res. 1996. PMID: 8752180
-
Hypercalcaemia and breast cancer--an increased humoral component in patients with liver metastases.Eur J Surg Oncol. 1988 Oct;14(5):423-8. Eur J Surg Oncol. 1988. PMID: 2846366
-
Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone.Endocr Relat Cancer. 2005 Sep;12(3):549-83. doi: 10.1677/erc.1.00543. Endocr Relat Cancer. 2005. PMID: 16172192 Review.
-
The mechanisms of human tumour-induced osteolysis and hypercalcaemia.Invest Cell Pathol. 1978 Apr-Jun;1(2):159-70. Invest Cell Pathol. 1978. PMID: 401332 Review.
Cited by
-
Prostaglandin F2 alpha and tumours of the female genital tract.Br Med J. 1978 Aug 5;2(6134):434-5. doi: 10.1136/bmj.2.6134.434-d. Br Med J. 1978. PMID: 687965 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources